Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial

SIMPLE SUMMARY: Diffuse large B-cell lymphoma (DLBCL) is an aggressive, heterogeneous non-Hodgkin B lymphoma, that 35% of cases produces relapsed/refractory (R/R) disease. At this point, the search of prognostic and predictive factors in DLBCL is indispensable through key biomarkers. Recently, we ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Cortegana, Carlos, Sánchez-Martínez, Pilar M., Palazón-Carrión, Natalia, Nogales-Fernández, Esteban, Henao-Carrasco, Fernando, Martín García-Sancho, Alejandro, Rueda, Antonio, Provencio, Mariano, de la Cruz-Merino, Luis, Sánchez-Margalet, Víctor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471526/
https://www.ncbi.nlm.nih.gov/pubmed/34572849
http://dx.doi.org/10.3390/cancers13184622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471526/
https://www.ncbi.nlm.nih.gov/pubmed/34572849
http://dx.doi.org/10.3390/cancers13184622

Ejemplares similares